Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Francisco Asensio is active.

Publication


Featured researches published by Francisco Asensio.


Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology | 2000

Screening of basidiomycetes for antimicrobial activities.

Inmaculada Suay; F. Arenal; Francisco Asensio; Angela Basilio; M. Angeles Cabello; M. Teresa Díez; Juan B. García; Antonio González del Val; Julian Gorrochategui; Pilar Hernández; Fernando Pelaez; M. Francisca Vicente

As a part of a screening programme developed to evaluate the antimicrobial activity of basidiomycetes, 317 isolates representing 204 species collected in Spain were screened against a range of human clinical pathogens and laboratory controls. Extracts from 45% of the isolates, representing 109 species, showed antimicrobial activity. Antibacterial activity was more pronounced than antifungal activity. The proportion of extracts from basidiomycetes showing antimicrobial activity was similar to or above that obtained for representative orders of Ascomycetes, such as Pezizales and Xylariales, but lower than that produced by members of the orders Diaporthales, Eurotiales, Hypocreales, Leotiales and Sordariales. Suprageneric taxa (orders and families) did not show pronounced differences in their antimicrobial activities though such differences were observed at the genus level, suggesting that the ability to produce these bioactive compounds is not homogenously distributed amongst the basidiomycetes. Isolates from some species showed large differences in their ability to produce metabolites with antimicrobial activity, possibly reflecting genetic differences at the infraspecific level.


Journal of Biomolecular Screening | 2012

A New Approach to Drug Discovery High-Throughput Screening of Microbial Natural Extracts against Aspergillus fumigatus Using Resazurin

Maria Cândida Monteiro; Mercedes de la Cruz; Juan Cantizani; Catalina Moreno; José R. Tormo; Emilia Mellado; J. Ramón De Lucas; Francisco Asensio; Vito Valiante; Axel A. Brakhage; Jean-Paul Latgé; Olga Genilloud; Francisca Vicente

Natural products are an inexhaustible source for drug discovery. However, the validation and selection of primary screening assays are vital to guarantee a selection of extracts or molecules with relevant pharmacological action and worthy of following up. The assay must be rapid, simple, easy to implement, and produce quick results and preferably at a low cost. In this work, we developed and validated a colorimetric microtiter assay using the resazurin viability dye. The parameters of the resazurin method for high-throughput screening (HTS) using natural extracts against Aspergillus fumigatus were optimized and set up. The extracts plus RPMI-1640 modified medium containing the spores and 0.002% resazurin were added per well. The fluorescence was read after 24 to 30 h of incubation. The resazurin proved to be as suitable as Alamar Blue for determining the minimal inhibitory concentration of different antifungals against A. fumigatus and effective to analyze fungicidal and fungistatic compounds. An HTS of 12 000 microbial extracts was carried out against two A. fumigatus strains, and 2.7% of the extracts displayed antifungal activity. Our group has been the first to use this methodology for screening a collection of natural extracts to identify compounds with antifungal activity against the medically important human pathogen A. fumigatus.


Journal of Biomolecular Screening | 2014

High-Content Screening of Natural Products Reveals Novel Nuclear Export Inhibitors

Bastien Cautain; Nuria de Pedro; Virginia Murillo Garzón; María Muñoz de Escalona; Víctor González Menéndez; José R. Tormo; Jesús Martín; Noureddine El Aouad; Fernando Reyes; Francisco Asensio; Olga Genilloud; Francisca Vicente; Wolfgang Link

Natural products are considered an extremely valuable source for the discovery of new drugs against diverse pathologies. As yet, we have only explored a fraction of the diversity of bioactive compounds, and opportunities for discovering new natural products leading to new drugs are huge. In the present study, U2nesRELOC, a previously established cell-based imaging assay, was employed to screen a collection of extracts of microbial origin for nuclear export inhibition activity. The fluorescent signal of untreated U2nesRELOC cells localizes predominantly to the cytoplasm. Upon treatment with the nuclear export inhibitor leptomycin B, the fluorescent-tagged reporter proteins appear as speckles in the nucleus. A proprietary collection of extracts from fungi, actinomycetes, and unicellular bacteria that covers an uncommonly broad chemical space was used to interrogate this nuclear export assay system. A two-step image-based analysis allowed us to identify 12 extracts with biological activities that are not associated with previously known active metabolites. The fractionation and structural elucidation of active compounds revealed several chemical structures with nuclear export inhibition activity. Here we show that substrates of the nuclear export receptor CRM1, such as Rev, FOXO3a and NF-κB, accumulate in the nucleus in the presence of the fungal metabolite MDN-0105 with an IC50 value of 3.4 µM. Many important processes in tumor formation and progression, as well as in many viral infections, critically depend on the nucleocytoplasmic trafficking of proteins and RNA molecules. Therefore, the disruption of nuclear export is emerging as a novel therapeutic approach with enormous clinical potential. Our work highlights the potential of applying high-throughput phenotypic imaging on natural product extracts to identify novel nuclear export inhibitors.


Journal of Applied Microbiology | 2002

Comparison of genotypic and phenotypic techniques for assessing the variability of the fungus Epicoccum nigrum

F. Arenal; Gonzalo Platas; Jesús Martín; Francisco Asensio; Oscar Salazar; Javier Collado; Francisca Vicente; Angela Basilio; C. Ruibal; Inmaculada Royo; N. De Pedro; Fernando Pelaez

Aims: The diversity within a collection of worldwide isolates of Epicoccum nigrum has been studied using several phenotypic approaches. In addition, the abilities of phenotypic and genotypic techniques for the differentiation of a set of isolates are compared.


Mycology | 2014

Assessing the effects of adsorptive polymeric resin additions on fungal secondary metabolite chemical diversity

Víctor González-Menéndez; Francisco Asensio; Catalina Moreno; Nuria de Pedro; Mc Monteiro; Mercedes de la Cruz; Francisca Vicente; Gerald F. Bills; Fernando Reyes; Olga Genilloud; José R. Tormo

Adsorptive polymeric resins have been occasionally described to enhance the production of specific secondary metabolites (SMs) of interest. Methods that induce the expression of new chemical entities in fungal fermentations may lead to the discovery of new bioactive molecules and should be addressed as possible tools for the creation of new microbial chemical libraries for drug lead discovery. Herein, we apply both biological activity and chemical evaluations to assess the use of adsorptive resins as tools for the differential expression of SMs in fungal strain sets. Data automation approaches were applied to ultra high performance liquid chromatography analysis of extracts to evaluate the general influence in generating new chemical entities or in changing the production of specific SMs by fungi grown in the presence of resins and different base media.


PLOS ONE | 2015

Identification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas Species

Bastien Cautain; Nuria de Pedro; Christian Schulz; Javier Pascual; Thiciana S. Sousa; Jesús Martín; Ignacio Pérez-Victoria; Francisco Asensio; Ignacio González; Gerald F. Bills; Fernando Reyes; Olga Genilloud; Francisca Vicente

Throughout recent history, metabolites of microbial origin have had an extraordinary impact on the welfare of humanity. In fact, natural products have largely been –and still are– considered an exceedingly valuable platform for the discovery of new drugs against diverse pathologies. Such value is partly due to their higher complexity and chemical diversity as compared to those of synthetic and combinatorial compounds. Mutations in the Von Hippel-Lindau (vhl) gene are responsible for VHL disease, congenital polycythemia, and are found in many sporadic tumor types. The primary cause of morbidity and mortality for these patients arises from progression of Renal Cell Carcinoma (RCC) or end-stage renal disease. Inactivation of the Von Hippel-Lindau (vhl) tumor suppressor gene arises in the majority of Renal Cell Carcinoma (RCC) as well as in other types of cancer and is associated with a high degree of vascularization and poor prognosis. Loss of pVHL function thus represents a pathognomonic molecular defect for therapeutic exploitation. In this study, renal carcinoma cell lines with naturally occurring vhl mutations (RCC4 VA) and their genetically matched wild-type vhl (RCC4 VHL) counterparts were seeded onto 96-well plates and treated with a collection of 1,040 organic extracts obtained from 130 bacterial strains belonging to at least 25 genera of the phyla Actinobacteria, Firmicutes, Proteobacteria and Bacteroidetes. This strategy allowed us to identify several extracts obtained from bacterial strain F-278,770T, the type strain of the recently proposed new species Pseudomonas granadensis, showing biological activities not associated with previously known bioactive metabolites. The fractionation and structural elucidation of one of these extracts led to the discovery of a new lipodepsipeptide (MDN-0066) with specific toxicity in pVHL deficient cells that is not detectable in cells with pVHL expression rescue. This specific toxicity is associated with apoptosis induction in VHL deficient cell line as demonstrated with PARP activation and Annexin V staining. Our study demonstrated the feasibility of selectively targeting the loss of the vhl tumor suppressor gene for potential clinical benefit. Our results may have great impact on the development of new targeted therapies from natural products for the treatment of cancer and other genetic diseases.


Journal of Biomolecular Screening | 2015

A Novel In Vitro Approach for Simultaneous Evaluation of CYP3A4 Inhibition and Kinetic Aqueous Solubility

Jose R. Perez; Caridad Díaz; Francisco Asensio; Alexandra Palafox; Olga Genilloud; Francisca Vicente

In the early stages of the drug discovery process, evaluation of the drug metabolism and physicochemical properties of new chemical entities is crucial to prioritize those candidates displaying a better profile for further development. In terms of metabolism, drug–drug interactions mediated through CYP450 inhibition are a significant safety concern, and therefore the effect of new candidate drugs on CYP450 activity should be screened early. In the initial stages of drug discovery, when physicochemical properties such as aqueous solubility have not been optimized yet, there might be a large number of candidate compounds showing artificially low CYP450 inhibition, and consequently potential drug–drug interaction toxicity might be overlooked. In this work, we present a novel in vitro approach for simultaneous evaluation of CYP3A4 inhibition potential and kinetic aqueous solubility (NIVA-CYPI-KS). This new methodology is based on fluorogenic CYP450 activities and turbidimetric measurements for compound solubility, and it provides a significant improvement in the use of resources and a better understanding of CYP450 inhibition data.


Journal of Biomolecular Screening | 2004

FIZICS: Fluorescent Imaging Zone Identification System, A Novel Macro Imaging System

Stephen Skwish; Francisco Asensio; Gregking; Glenn A. Clarke; Gary S. Kath; Michael J. Salvatore; Claude Dufresne

Constantly improving biological assay development continues to drive technological requirements. Recently, a specification was defined for capturingwhite light and fluorescent images of agar plates ranging in size from theNUNCOmnitray (96-well footprint, 128 · 85 mm) to the NUNC Bio Assay Dish (245 · 245 mm). An evaluation of commercially available products failed to identify any systemcapable of fluorescentmacroimaging with discretewavelength selection. To address the lack of a commercially available system, a customimaging systemwas designed and constructed. This systemprovides the same capabilities ofmany commercially available systemswith the added ability to fluorescently image up to a 245 · 245mmarea using wavelengths in the visible light spectrum.


Renewable energy & power quality journal | 2017

Empirical-Analytical Modelling of the Thermal Performance of a PEMFC-based CHP System

Francisco Asensio; J.I. San Martín; I. Zamora; G. Saldaña; Ira H. Martin

This paper focuses on the thermal modelling of a CHP system based on Proton Exchange Membrane Fuel Cell (PEMFC) by experimental analysis and analytical relationships. To this end, there have been carried out several experimental tests on a PEMFC 600 W of electrical power in order to obtain the necessary data for thermal modelling and its subsequent validation. Once made the experimental analysis, data obtained have been used to develop the thermal model of the stack of the fuel cell as well as the entire temperature management system, by implementing various analytical relationships in the MATLAB/Simulink environment. The model obtained has allowed to characterize the thermal behaviour of the fuel cell to different profiles of electrical and thermal energy demand, with a minimum and maximum relative error in the temperature of the stack of 3.77% and 11.05%, respectively.


Renewable energy & power quality journal | 2017

Testing and analysis of a fuel cell based stand-alone power system for residential use

J. García-Villalobos; I. Zamora; J.I. San Martín; Francisco Asensio; I. Junquera

Nowadays, there are residential buildings which cannot be connected to a distribution network, due to the lack of electric infrastructure. Also, there are other electric applications where it is necessary to have a back-up system, i.e. hospitals, hotels, etc. Additionally, there are users who just want to be off-grid. In all these cases, a dedicated stand-alone generation system can provide a valuable service. In this context, this paper is focused on testing and analysis of a real small stand-alone generation system composed by two proton membrane exchange fuel cells (PEMFC) and a micro wind generator (WG). The key feature of this configuration is to be an on-site zero-emission system. Additionally, quality of supply and energy efficiency of this microgrid in islanded mode are analyzed. Furthermore, possible optimization methods and future enlargements of the system are proposed, in order to improve the overall efficiency of the proposed microgrid.

Collaboration


Dive into the Francisco Asensio's collaboration.

Top Co-Authors

Avatar

I. Zamora

University of the Basque Country

View shared research outputs
Top Co-Authors

Avatar

J.I. San Martín

University of the Basque Country

View shared research outputs
Top Co-Authors

Avatar

Gerald F. Bills

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge